Research collaboration to target severe form of genetic dilated cardiomyopathy
Collaboration strengthens Solid Biosciences’ scientific capabilities and commercial potential in cardiac therapy
Collaboration allows Phlox Therapeutics to leverage Solid Biosciences’ vector biology and manufacturing capacities to deliver its RNA therapies to the heart
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.